terol by means of directly measuring the A340 of NAD(P)H, are useful for clinical purposes. The amino acid sequences of the NH2 terminus and the fragments obtained by CNBr decomposition of the NAD(P)-CDH from a Nocardia sp. were determined for preparation of synthetic oligonucleotides as hybridization probes. A 4.4-kbp BamHI fragment hybridizing to these probes was cloned on pUCl9 in Escherichia coli. The nucleotide sequence together with the determined amino acid sequences revealed that this enzyme consists of 364 amino acids (Mry 39,792) and contains an NAD(P)-binding consensus sequence at its NH2-terminal portion. Highresolution Si nuclease mapping suggested that in NAD(P)-CDH of both Nocardia and Streptomyces spp. transcription initiates at the adenine residue, which is the first position of the translational initiation triplet (AUG) of this protein. The Si mapping experiments also showed that cholesterol-dependent regulation in the Nocardia sp. occurred at the level of transcription. In Streptomyces lividans containing the cloned fragment, however, this promoter was expressed constitutively. DNA manipulation of the cloned gene in E. coli, including the generation of a ribosome-binding sequence at an appropriate position by oligonucleotide-directed mutagenesis, led to production of this protein in a very large amount but in the enzymatically inactive form of inclusion bodies. On the other hand, a Streptomyces host-vector system was successfully used for producing 40 times as much enzymatically active NAD(P)-CDH as that produced by the original Nocardia sp.
Nocardia sp. strain Ch 2-1 (2) was discovered during a wide screening test for microorganisms that produce an NAD-or NADP-dependent cholesterol dehydrogenase [NAD(P)-CDH]. The enzyme produced by this strain specifically oxidizes the 3B-OH group of cholesterol with a high substrate specificity (cholesterol + NAD+-* cholestenone + NADH + H+) and is successfully used as a diagnostic enzyme for measurement of cholesterol in blood (1) . The colorimetric assay of cholesterol with a cholesterol oxidase is often affected by bilirubin and ascorbic acid in blood. The method with NAD(P)-CDH overcomes this problem and allows easier and direct quantification of cholesterol by measuring the A340 of NADH as an index.
One of the purposes of this study was to improve the yield of NAD(P)-CDH by using recombinant DNA techniques, since the Nocardia sp. produces only a small amount of this enzyme and since control of the culture conditions which determine maximum yield of the enzyme is rather difficult. Our first attempt to produce the enzyme in Escherichia coli through DNA manipulation of the cloned gene was not successful; a very large amount of the NAD(P)-CDH protein produced in E. coli was enzymatically inactive because of the formation of inclusion bodies. However, we have succeeded in producing the active enzyme in large amounts by using a Streptomyces host-vector system. a Another purpose of this study was to analyze the cholesterol-inducible promoter of this gene. In the Nocardia sp., no detectable NAD(P)-CDH is produced in the absence of cholesterol. We have determined the nucleotide sequence and transcriptional start point of the promoter and have found that the induction by cholesterol occurs through * Corresponding author. transcriptional activation. On the other hand, this promoter is shown to be constitutively expressed in Streptomyces spp. The Si mapping also revealed an unusual transcriptiontranslation feature of this gene: the transcriptional start point is the first codon position of the translation initiation triplet AUG.
MATERIALS AND METHODS
Bacterial strains and plasmids. Nocardia sp. strain Ch 2-1 producing NAD(P)-CDH (1, 2) was provided by Amano Pharmaceutical Co. Ltd., Nagoya, Japan. E. coli JM109 [A(lac pro) thi-l endAl gyrA96 hsdRl 7 relAl recAl F' traD36 proAB lacIq lacZAM15] (29) was used as the host for initial cloning and expression of the cloned gene and for phage M13 propagation. Streptomyces lividans TK24 (str-6 SLP2-SLP3), obtained from D. A. Hopwood (11) , John Innes Institute, Norwich, United Kingdom, was used as the host for manipulation and expression of the cloned gene. Streptomyces griseus IFO 13350 was also used for expression of the Nocardia gene. Ampicillin resistance plasmid pUC19 (29) containing the lac promoter was used as the expression plasmid in E. coli. As a vector plasmid for the Streptomyces spp., pIJ385 (thiostrepton and neomycin resistance [10] ) and pIJ486 (thiostrepton resistance [27] ) were used. A promoter-probe plasmid pARC1 (thiostrepton resistance [12] ) was used for detecting the promoters. Phage M13 derivatives, M13mpl8 and M13mpl9 (29) , were purchased from Amersham International.
Enzymes and chemicals. Restriction endonucleases, T4 DNA ligase, and other DNA-modifying enzymes were purchased from Takara Shuzo, Co., Ltd, or Boehringer-Mannheim GmbH. Achromobacter peptidase was from Wako mmol) and [y-32P]ATP (5, 000 Ci/mmol) were from Amersham. Thiostrepton was a gift from Asahi Chemical Industry, Shizuoka, Japan.
Determination of amino acid sequences of NAD(P)-CDH. NAD(P)-CDH was purified by a previously described method (2) . Briefly, cells of Nocardia sp. strain Ch 2-1 were disrupted with glass beads, and the cell extract was obtained by centrifugation. Proteins were precipitated with ammonium sulfate (35% saturation). NAD(P)-CDH was further purified by successive chromatography on DEAE-cellulose and hexyl-Sepharose. For NH2-terminal amino acid sequence determination by automated Edman degradation, an Applied Biosystems 470A sequencer was used. CNBr-decomposed polypeptides that had been separated by highperformance liquid chromatography after a standard CNBr treatment of the enzyme were similarly sequenced.
Synthesis of oligonucleotide probes. Two NAD(P)-CDHspecific oligonucleotides designed from the protein sequence data including its NH2-terminal sequence were synthesized by the phosphoamidite method with an Applied Biosystems 380B DNA synthesizer. The oligonucleotides were purified by 15% polyacrylamide gel electrophoresis, labeled at their 5' ends with T4 polynucleotide kinase and [-y-32P]ATP, and used as hybridization probes.
Oligonucleotide screening of the NAD(P)-CDH gene. General techniques including transformation of E. coli cells, plasmid DNA isolation, and agarose gel electrophoresis were described by Maniatis et al. (18) . Chromosomal DNA of the Nocardia sp. was prepared after lysis of cells with lysozyme and Achromobacter peptidase followed by CsCl ultracentrifugation. Southern hybridization between BamHI-digested chromosomal DNA and the 32P-labeled oligonucleotide probes described above was carried out according to the method of Southern (26) with the following modifications. The temperature for hybridization in 0.9 M NaCl-6 mM EDTA-90 mM Tris HCl (pH 7.5)-0.5% Nonidet P-40 (Sigma) was 25°C, and the nitrocellulose blot was washed twice at 45°C. A distinct 4.0-kb band hybridizing to the two probes was detected. From an agarose gel slice containing BamHI fragments in the size range of 3.8 to 4.5 kb, DNA was recovered by the sodium perchlorate method (6) and ligated with linear molecules of pUC19 which had been successively treated with BamHI and bacterial alkaline phosphatase. The ligated mixture was introduced by transformation into E. coli JM109, and ampicillin-resistant and nonblue transformants were selected on L broth (20) containing 50 ,ug of ampicillin per ml and X-Gal (5-bromo-4-chloro-3-indolyl-,-D-galactopyranoside). Colony hybridization (8) (12) .
For high-resolution S1 protection mapping, total cellular RNAs from exponentially growing Nocardia sp. strain Ch 2-1 and S. lividans harboring pCD5 in the presence and absence of 5 mg of cholesterol per ml were prepared by using lysozyme-sodium dodecyl sulfate (SDS) and hot phenol as previously described (13) . For Preliminary experiments had shown that the NAD(P)-CDH enzyme was produced in the form of inclusion bodies, and For construction of pCD3, an SD sequence, GGAGG, was generated 8 bp upstream from the ATG start codon by oligonucleotide-directed mutagenesis, as shown. Circled numbers 1 to 4 below the enlarged restriction map show the restriction fragments which were tested for a promoter activity by using the promoter-probe vector pARC1.
therefore we used the low-speed centrifugation which is usually employed for collecting inclusion bodies. Each fraction was assayed for NAD(P)-CDH activity by the method described above and also by 0.1% SDS-10.0% polyacrylamide gel electrophoresis (17) . Protein bands were visualized by staining with Coomassie brilliant blue.
For the assay of NAD(P)-CDH activity in the cell extract from the Streptomyces spp., the strains containing plasmids were grown at 30°C for 2 days in medium containing the following (per liter): glucose, 10 g; Meast PlG (Asahi Beer Co.), 5 g; cultivater (fish meat extract; Yaizu-Suisan Co.), 10 g; Snow-peptone (Yukijirushi), 5 g; K2HPO4, 3.5 g; KH2PO4, 1 g; MgSO4 7H20, 0.1 g; Adekanol (defoamer), 1 drop; and 5 [Lg of thiostrepton per ml. Three milliliters of the culture was transferred to 100 ml of the same medium and incubated at 30°C on a reciprocal shaker. The mycelium was collected by filtration with Toyo filter paper no. 2 and disrupted by grinding with A1203 (five-times-greater mass than that of the mycelium) in a mortar. To the disrupted mycelium, 5 ml of 0.1 M potassium phosphate buffer (pH 7.0) containing 0.1% Triton X-100 was added. The supernatant was used for the enzyme assay after centrifugation at 12,000 x g for 30 min.
Nucleotide sequence accession number. The nucleotide sequence of the NAD(P)-CDH gene has been submitted in the DDBJ, EMBL, and GenBank Nucleotide Sequence Data bases with the accession number D90244.
RESULTS
Cloning of the NAD(P)-CDH gene. NAD(P)-CDH was purified from Nocardia sp. strain Ch 2-1, and its NH2-terminal amino acid sequence along with the partial amino acid sequences for two CNBr-decomposed fragments was determined. On the basis of these amino acid sequences, two 32-mer oligonucleotides in which inosines are used for all the bases corresponding to the third codon positions were synthesized, as described in Materials and Methods. For the NH2-terminal sequence, Gly-Asp-Ala-Ser-Leu-Thr-ThrAsp-Leu-Gly-Cys-Val-Leu-Val-Thr-Gly-X-Ser-Gly-Phe (where X stands for an amino acid which was not unambiguously determined), a 32-mer nucleotide sequence (probe I) corresponding to the amino acids from the 6th Thr to the 16th Gly, ACI ACI GAI CTI GGI TGI GTI CTI GTI ACI GG, was synthesized. For one of the amino acid sequences determined from the CNBr-decomposed fragments, Phe-XLys-X-Phe-Glu-Asn-Val-Leu-Ala-Gly-His-Val-Lys-ValLeu-Val-Gly-Asn-Lys, a 32-mer nucleotide sequence (probe II) corresponding to the amino acid sequence from the 10th Ala to the 20th Lys, GCI GGI CAI GTI AAI GTI CTI GTI GGI AAI AA, was also synthesized. The synthetic DNA (probe I) designed for the NH2-terminal amino acid sequence was used as the hybridization probe for the initial cloning of the NAD(P)-CDH gene.
Southern blot hybridization between 32P-labeled probe I and the Nocardia sp. chromosomal DNA digested with BamHI gave more than 10 bands giving positive signals with various intensities (data not shown). We chose the band (approximately 4 kb) that showed the strongest signal for the candidate of the target gene. The BamHl-digested fragments of 3.8 to 4.5 kb were purified by agarose gel electrophoresis, ligated with BamHl-digested pUC19 DNA, and introduced by transformation into E. coli JM109. About 220 ampicillinresistant transformants which did not turn blue on an X-Gal plate were screened by colony hybridization with probes I and TI. One colony showing positive hybridization to both probes was obtained. Figure 1 shows the restriction map of the plasmid, named pCD1. Southern hybridization experiments with purified pCD1 DNA containing a 4.4-kb BamHT fragment revealed that probes I and IT hybridized to the same 0.95-kb SmaI fragment in the cloned fragment.
Nucleotide sequence of the NAD(P)-CDH gene. On the basis of the results described above, we determined the nucleotide sequence of the NAD(P)-CDH gene by the chain-terminating Fig. 1 . Four Gly residues in the NAD(P)-binding consensus sequence, Gly-X-Gly-(X)2-Gly-(X)1O-Gly, are indicated by double underlines. The bent arrow at nt 243 indicates the transcriptional start point, as determined by S1 nuclease mapping (see Fig. 5 ). The -35 and -10 sequences with some similarity to procaryotic consensus sequences are also shown. Three pairs of inverted repeat sequences upstream of the coding region are shown by opposing arrows.
dideoxynucleotide method (29) , according to the strategy shown in Fig. 1 . The whole nucleotide sequence was determined in both orientations, and all the restriction sites used for cloning were verified by determination as part of an overlapping sequence. Figure 2 shows Fig. 3 . The overall average G+C composition of the coding region is 63.7 mol%, and those of codon positions 1, 2, and 3 are 61.9, 40.3, and 88.8 mol%, respectively. The relatively high G+C content is reflected preferentially at the third codon position. Such a codon usage pattern is characteristic for genes with a high G+C content from various bacteria (4). For determination of the transcriptional start point by S1 mapping, we constructed plasmid pCD5 (Fig. 4) , in which the NAD(P)-CDH gene was located downstream of the rho-independent transcriptional terminator in pIJ486 (27) , in order to avoid possible effects caused by read-through from the vector sequence. This plasmid was also used for production of the enzyme, as shown below. High-resolution S1 mapping with total RNAs from S. lividans containing pCD5 which was grown in the presence and absence of cholesterol was conducted with the 32P-labeled SmaI-Narl fragment (nt 1 to 309). A transcriptional start point was determined to be nt 243 (Fig. 5) . This residue, A, was the first position of the translational start ATG codon. The 32P-signals for RNAs prepared in the presence and absence of cholesterol were almost the same in intensity; this is consistent with the results described above obtained by use of the promoterprobe plasmid pARC1.
On the other hand, similar experiments with RNAs prepared from the Nocardia sp. clearly showed that the promoter was induced by cholesterol in the Nocardia sp. cells. The transcriptional start points in the Nocardia sp. and S. lividans were the same. It was therefore concluded that the inducible production of NAD(P)-CDH by cholesterol resulted from the transcriptional stimulation of the gene in some unknown way.
The nucleotide sequence (5'-TCGAAA-3' for -35 and 5'-TAAGCT-3' for -10, with a 17-bp space) upstream from the transcriptional start point showed some similarity to consensus sequences (5'-TTGACA-3' for -35 and 5'-TATAAT-3' for -10, with a 17-bp space) for other procaryotic promoters (22) . It also showed similarity to one type (5'-TTGACA-3' for -35 and 5'-TAGGAT-3' for -10, with a 18-bp space) of Streptomyces promoter, which is believed to be active during the vegetative growth (9) . The NAD(P)-CDH gene is most likely expressed in Streptomyces spp.
because the consensus sequence of its promoter sequence is similar to that of one class of Streptomyces promoters.
Streptomyces spp. allow expression of most procaryotic promoters with the consensus sequences (3). The observation that NAD(P)-CDH expression is constitutive in S. ( shown by an open arrow) was excised by digestion of pCD1 with PstI and ligated with PstI-digested pIJ385. The PstI site on pIJ385 is in the neo gene. The ligated mixture was introduced by transformation into protoplasts of S. lividans TK24, and they were regenerated on R2YE medium (10). Transformants were selected by replication onto Bennett agar medium containing 30 pug of thiostrepton per ml. The plasmid pCD4, obtained in this way, contains the NAD(P)-CDH gene in the same orientation as that of transcription of the neo gene. Plasmid pCD5 was constructed by insertion of the 3.3-kb BamHI-EcoRI fragment containing the whole NAD(P)-CDH gene into the multilinker site of pIJ486. The NAD(P)-CDH gene in pCD5 is located downstream of a transcriptional terminator derived from E. coli phage fd. This terminator was shown to prevent significant transcriptional read-through from the vector sequence (27) .
lividans suggests that the Nocardia sp. CDH regulatory proteins are not present in S. lividans.
Expression of the NAD(P)-CDH gene in E. coli. First we attempted to express the cloned gene by using E. coli host-vector systems. Because of the absence of a possible ribosome-binding sequence (SD [24] ) at an appropriate position upstream of the translational start codon of NAD(P)-CDH, we generated a GGAGG sequence 8 bp upstream of the start codon by oligonucleotide-directed mutagenesis, as shown in Fig. 1 . The NAD(P)-CDH gene with the artificial SD sequence was then placed downstream of the lac promoter in pUC19, resulting in pCD3. We also constructed a pCD2 plasmid in which the NAD(P)-CDH gene was placed in the opposite orientation to that in pCD1 (Fig. 1) sity. The 5' terminus of the mRNA is assigned to the indicated position, because the fragments generated by the chemical sequencing reactions migrate 1.5 nt further than the corresponding fragments generated by S1 nuclease digestion of the RNA-DNA hybrids (half a residue from the presence of the 3'-terminal phosphate group and one residue from the elimination of the 3'-terminal nucleotide) (25) . Similarly, total RNAs (30 ,ug each) from Nocardia sp. strain Ch 2-1 grown in the presence and absence of cholesterol were used for S1 mapping. The terminus of mRNA is the same as that produced in S. lividans. In addition, it is clear that cholesterol induces the expression of this promoter.
JM109 harboring pCD1, pCD2, or pCD3 was cultured, and the lac promoter was induced by the addition of IPTG. However, no NAD(P)-CDH activity was detected in either the particulate or soluble fraction from any transformant. SDS-polyacrylamide gel electrophoresis of the particulate fraction of E. coli harboring pCD3 showed that the NAD(P)-CDH protein was produced in a very large amount, depending on the presence of IPTG (Fig. 6 ). The NAD(P)-CDH protein composed about 10% of the total proteins of E. coli cells. In addition, to our surprise, plasmid pCD1, which we used as a reference in this experiment, also directed the synthesis of the NAD(P)-CDH protein in almost the same amount as did pCD3 (data not shown). This implies that in E. coli some sequence serves as an efficient SD sequence. The most probable candidate is AAG (nt 231 to 233), which is located 9 bp upstream of the ATG start codon. Microscopic observation of IPTG-induced E. coli cells harboring pCD1 or pCD3 revealed an inclusion body in each cell. It seems probable that the NAD(P)-CDH protein was produced in a large amount in the inactive from of inclusion bodies.
Plasmid pCD2 failed to direct the synthesis of the NAD(P)-CDH protein, presumably because transcription of the NAD(P)-CDH gene initiates at the lac promoter in E. coli cells containing pCD1 and pCD3 and because the promoter of the NAD(P)-CDH gene is not functional in E. coli. As described above, the promoter signal of the NAD(P)-CDH gene has similarity to the consensus promoter signal of E. coli. It is well conceivable that notwithstanding its similarity, this promoter is not functional in E. coli. This is consistent with the observations that most promoters from Streptomyces spp., and probably from Nocardia spp., are not recognized by the E. coli transcriptional machinery (3, 15 Fig. 7 , this strain produced 397 U of active NAD(P)-CDH per 100 ml of culture, whereas S. lividans containing only the vector plasmid pIJ385 produced no NAD(P)-CDH. The NAD(P)-CDH protein that accumulated in the cells was detected as a thick band on SDS-polyacrylamide gels (Fig. 7B) .
The activity specified by this recombinant S. lividans strain was about 40 times higher than that by the original Nocardia sp. The maximum activity obtained with the Nocardia sp. amounted to only 10 to 20 U per 100 ml of culture when grown in the presence of cholesterol as an inducer, despite many efforts at improving the yield. In addition, control of the culture for stable production of the enzyme had been a problem to be solved.
DISCUSSION
DNA manipulation using E. coli systems often resulted in production of proteins in the inactive form of inclusion bodies, which is usually very difficult to be refolded into an active form. The NAD(P)-CDH protein of the Nocardia sp.
was produced as inclusion bodies as well. The use of a Streptomyces host-vector system, however, not only overcame this difficulty but also led to a great yield enhancement of the enzyme. The recombinant S. lividans strain stably produced the NAD(P)-CDH enzyme in the absence of cholesterol as an inducer; this is important from a practical point of view.
The putative promoter of the NAD(P)-CDH gene having similarity to -35 and -10 consensus sequences of other procaryotes, including Streptomyces spp., was constitutively expressed at a high level in S. lividans and S. griseus. This promoter was highly active only in the presence of cholesterol in the original Nocardia strain. One possibility is that a certain repressor protein is involved in the induction and that the gene coding for this putative protein is not contained in the cloned fragment. This may be an explanation for constitutive expression of the NAD(P)-CDH gene in Streptomyces spp. Cholesterol may release the repression caused by a protein which binds to the promoter region and which represses its expression. Alternatively, cholesterol may bind a protein which is required as a positive regulator to initiate transcription from this promoter. In relation to this speculative repressor or activator, three pairs of inverted repeat sequences are present, two of which cover the -35 and -10 regions of the cholesterol-inducible promoter (Fig.  2) . One or some of these inverted repeats may be associated with the cholesterol-dependent regulation in some way.
The translation of the leaderless transcript presents a striking contrast to the conventional ribosome-SD sequence contact in translational initiation in other procaryotes (7) . In Streptomyces spp., the same translation feature has been reported for several antibiotic resistance genes (5, 13, 16) and the A-factor production gene (14) , whose expression is strictly controlled depending on the growth phases. One of the two promoters for the repressor gene of E. coli bacteriophage A also shows an unusual transcription-translation feature (21) . Contrary to the case for these Streptomyces genes, there seems to be no reason for the Nocardia sp. to produce the NAD(P)-CDH protein at a certain stage of growth. In fact, the Nocardia sp. begins to produce NAD(P)-CDH at an early stage of growth and then continues its production (data not shown). The recombinant S. lividans strain containing pCD4 also appears to produce NAD(P)-CDH at an early stage of growth, since the amount of NAD(P)-CDH increases with the growth measured in terms of the cell weight (Fig. 7A) . Although an extensive study is apparently required, this finding suggests that the translation of leaderless transcripts is distributed more widely than expected.
